Description: MEDIPOST Co., Ltd. provides stem cell therapeutic solutions to meet the unmet medical needs in South Korea and internationally. It operates CELLTREE, an umbilical cord blood bank; and offers cord blood banking services to treat various incurable diseases. The company also markets CARTISTEM for the treatment of repetitive and/or traumatic cartilage degeneration, including degenerative osteoarthritis. In addition, it is developing stem cell drugs, such as PNEUMOSTEM, which is in completed Phase II clinical trial in South Korea, as well as in Phase I/II clinical trial in the United States for the preventative treatment of bronchopulmonary dysplasia; and NEUROSTEM that is in Phase I/IIa clinical study to treat Alzheimer's disease. Further, the company develops SMUP-IA-01, which has completed phase I clinical trial for the treatment of osteoarthritis; and SMUP-IV-01 for the treatment of diabetic nephropathy, as well as offers nutritional and dietary supplements under the MOVITA brand name. MEDIPOST Co., Ltd. was founded in 2000 and is headquartered in Seongnam, South Korea.
Home Page: www.medi-post.co.kr
21, Daewangpangyo-ro
Seongnam-si,
South Korea
Phone:
82 2 3465 6677
Officers
| Name | Title |
|---|---|
| Dr. Won-II Oh M.D., Ph.D. | Gen. Director of Laboratory, VP and Director |
| Mr. Jang-Won Lee | Sr. Managing Director and Exec. Director |
| Dr. Yoon-Seon Yang | CEO & Pres |
| Dr. Sung-Ho Han Ph.D. | Head Mang. of Bus. Devel. Division and Director |
| Dr. Soo-Jin Choi M.D., Ph.D. | Director of Research Department and Director |
| Mr. Young-Hwan Song | Head Mang. of Management Support Division and Director |
| Ms. Hye-Kyung Hong | Director of 1st Research Department and Director |
Exchange: KQ
Country: KR : Korea (Republic of)
Currency: Korean Won (₩)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Health Care Equipment & Services |
| GIC Industry: | Health Care Providers & Services |
| GIC Sub-Industry: | Health Care Services |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 4.234 |
| IPO Date: | 2005-07-29 |
| Fiscal Year End: | December |
| Full Time Employees: | 267 |